We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

European Commission ups the cost of paying for delay

  • King & Wood Mallesons
  • -
  • Australia, European Union, USA
  • -
  • August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram

Breaking news: hard Medicine for group members to take - Full Court overturns decision in VIOXX class action

  • King & Wood Mallesons
  • -
  • Australia, USA
  • -
  • October 12 2011

The Full Court of the Federal Court of Australia has overturned the 2010 decision that marked the first successful class action ruling in the world in relation to arthritis drug VIOXX

Competition regulators continue their campaign against pharmaceutical companies

  • King & Wood Mallesons
  • -
  • Australia, USA
  • -
  • June 1 2011

Last month, the US Federal Trade Commission (FTC) released its findings on reverse payment settlements between pharmaceutical companies in the 2010 US fiscal year

2nd Ave Deli to Heart Attack Grill: “kiss my tuchas”

  • King & Wood Mallesons
  • -
  • Australia, USA
  • -
  • May 20 2011

Last year we blogged about the Heart Attack Grill in Arizona - a medically themed hamburger restaurant with fat-laden food served by waitresses dressed as nurses - and its action against Heart Stoppers Sports Grill for copying its idea